NM4-25348-17892
3 vaccinations
2 coded responses
6 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 930 / CA
- Registered
- 2022-11-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-17
Dose 1 — Moderna
-
2021-02-14
Dose 2 — Moderna
-
2022-11-16
Registered in v-safe
-
2022-11-16
Dose 3 — Pfizer-BioNTech
-
2022-11-17
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oropharyngeal pain — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pain in arm pit area, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Good · Site: Pain · NauseaFree text: Pain in armpitMedDRA releases: 2024-11 · check-in free text available
- 2022-11-19
- 2022-11-30
- 2022-12-14
- 2022-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-17 | Moderna | No |
| 2 | 2021-02-14 | Moderna | No |
| 3 | 2022-11-16 | Pfizer-BioNTech | No |
Free text
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Pain in arm pit area, sore throat
Systemic reaction (other): Pain in armpit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release